Cargando…

Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures

IMPORTANCE: Prescription drug spending in the US requires policy intervention to control costs and improve the value obtained from pharmaceutical spending. One such intervention is to apply cost-effectiveness evidence to decisions regarding drug coverage and pricing, but this intervention depends on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tisdale, Rebecca L., Ma, Iris, Vail, Daniel, Bhattacharya, Jay, Goldhaber-Fiebert, Jeremy D., Heidenreich, Paul A., Sandhu, Alexander T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214163/ https://www.ncbi.nlm.nih.gov/pubmed/34143189 http://dx.doi.org/10.1001/jamanetworkopen.2021.13969

Ejemplares similares

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Association of Medicare Part D Benzodiazepine Coverage Expansion With Changes in Fall-Related Injuries and Overdoses Among Medicare Advantage Beneficiaries
por: Maust, Donovan T., et al.
Publicado: (2020)

Estimating the cost of cervical cancer screening in five developing countries
por: Goldhaber-Fiebert, Jeremy D, et al.
Publicado: (2006)

Medicare Part A Utilization and Expenditures for Psychiatric Services: 1995
por: Cano, Carlos, et al.
Publicado: (1997)

Diabetes, Its Treatment, and Catastrophic Medical Spending in 35 Developing Countries
por: Smith-Spangler, Crystal M., et al.
Publicado: (2012)

Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018
por: Lakdawalla, Darius, et al.
Publicado: (2021)

Predictability of Prescription Drug Expenditures for Medicare Beneficiaries
por: Wrobel, Marian V., et al.
Publicado: (2003)

Spending on and Use of Clinician-Administered Drugs in Medicare
por: Hyland, Megan F., et al.
Publicado: (2023)

Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis
por: Goldhaber-Fiebert, Jeremy D., et al.
Publicado: (2023)

Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence
por: Cipriano, Lauren E., et al.
Publicado: (2018)

The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
por: Carvalho, Natalie, et al.
Publicado: (2019)

Comparison of Out-of-Pocket Spending on Ultra-Expensive Drugs in Medicare Part D vs Commercial Insurance
por: DiStefano, Michael J., et al.
Publicado: (2023)

Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar
por: Malloy, Giovanni S. P., et al.
Publicado: (2021)

Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis
por: Bernard, Cora L., et al.
Publicado: (2017)

Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program
por: Socal, Mariana P., et al.
Publicado: (2021)

Prevention and control of dengue and chikungunya in Colombia: A cost-effectiveness analysis
por: Claypool, Anneke L., et al.
Publicado: (2021)

Trends in Medicare Part B Mental Health Utilization and Expenditures: 1987-92
por: Rosenbach, Margo L., et al.
Publicado: (1997)

Geographic Variation in Medicare Fee-for-Service Health Care Expenditures Before and After the Passage of the Affordable Care Act
por: Sood, Neeraj, et al.
Publicado: (2021)

Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients
por: Liu, Shan, et al.
Publicado: (2011)

Effects of the Medicare Alzheimer's Disease Demonstration on Medicare Expenditures
por: Newcomer, Robert, et al.
Publicado: (1999)

Association Between Medicare Expenditures and Adverse Events for Patients With Acute Myocardial Infarction, Heart Failure, or Pneumonia in the United States
por: Wang, Yun, et al.
Publicado: (2020)

Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017
por: Guadamuz, Jenny S., et al.
Publicado: (2019)

Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries
por: Sumarsono, Andrew, et al.
Publicado: (2020)

Disease Control Implications of India's Changing Multi-Drug Resistant Tuberculosis Epidemic
por: Suen, Sze-chuan, et al.
Publicado: (2014)

Medicare Part B Spending on Macular Degeneration Treatments Associated With Manufacturer Payments to Ophthalmologists
por: Dickson, Sean R., et al.
Publicado: (2023)

Comparison of Costs of Care for Medicare Patients Hospitalized in Teaching and Nonteaching Hospitals
por: Burke, Laura G., et al.
Publicado: (2019)

Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement
por: Yala, Stella M, et al.
Publicado: (2014)

Uptake of COVID-19 Vaccination Among Frontline Workers in California State Prisons
por: Prince, Lea, et al.
Publicado: (2022)

Association of a Geriatric Emergency Department Innovation Program With Cost Outcomes Among Medicare Beneficiaries
por: Hwang, Ula, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
por: Liu, Shan, et al.
Publicado: (2013)

Health Costs and Outcomes Associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis
por: Park, Haesuk, et al.
Publicado: (2015)

Measuring the Scope of Prior Authorization Policies: Applying Private Insurer Rules to Medicare Part B
por: Schwartz, Aaron L., et al.
Publicado: (2021)

Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020
por: Dickson, Sean, et al.
Publicado: (2023)

Assessment of Prevalence and Cost of Care Cascades After Routine Testing During the Medicare Annual Wellness Visit
por: Ganguli, Ishani, et al.
Publicado: (2020)

Coverage of New Drugs in Medicare Part D
por: NACI, HUSEYIN, et al.
Publicado: (2022)

Trends in Costs of Care for Medicare Beneficiaries Treated in the Emergency Department From 2011 to 2016
por: Burke, Laura G., et al.
Publicado: (2020)

Association of Medicare Beneficiary and Hospital Accountable Care Organization Alignment With Surgical Cost Savings
por: Herrel, Lindsey A., et al.
Publicado: (2022)

Association of Health Insurance Literacy With Enrollment in Traditional Medicare, Medicare Advantage, and Plan Characteristics Within Medicare Advantage
por: Park, Sungchul, et al.
Publicado: (2022)

Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study
por: Lin, Eugene, et al.
Publicado: (2018)

Quantifying demographic and socioeconomic transitions for computational epidemiology: an open-source modeling approach applied to India
por: Basu, Sanjay, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7tbug7shli8ia81d8e4515fmsm